{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T16:18:21Z","timestamp":1778689101582,"version":"3.51.4"},"reference-count":52,"publisher":"Japanese Society of Toxicology","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Toxicol. Sci."],"published-print":{"date-parts":[[2025]]},"DOI":"10.2131\/jts.50.677","type":"journal-article","created":{"date-parts":[[2025,11,30]],"date-time":"2025-11-30T22:06:52Z","timestamp":1764540412000},"page":"677-690","source":"Crossref","is-referenced-by-count":1,"title":["Lenvatinib induces diarrhea in rats by promoting intestinal barrier injury via targeting AQP4"],"prefix":"10.2131","volume":"50","author":[{"given":"Guanbao","family":"Long","sequence":"first","affiliation":[{"name":"Department of Hepatic Biliary Pancreatic Surgery, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Hepatic Biliary Pancreatic Surgery, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chaowen","family":"Xiao","sequence":"additional","affiliation":[{"name":"Department of Hepatic Biliary Pancreatic Surgery, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu","family":"Tan","sequence":"additional","affiliation":[{"name":"Department of Hepatic Biliary Pancreatic Surgery, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changchun","family":"Cai","sequence":"additional","affiliation":[{"name":"Department of Hepatic Biliary Pancreatic Surgery, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"898","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"Blair, S.A., Kane, S.V., Clayburgh, D.R. and Turner, J.R. (2006): Epithelial myosin light chain kinase expression and activity are upregulated in inflammatory bowel disease. Lab. Invest., <b>86<\/b>, 191-201.","DOI":"10.1038\/labinvest.3700373"},{"key":"2","doi-asserted-by":"crossref","unstructured":"Buckley, A. and Turner, J.R. (2018): Cell Biology of Tight Junction Barrier Regulation and Mucosal Disease. Cold Spring Harb. Perspect. Biol., <b>10<\/b>, a029314.","DOI":"10.1101\/cshperspect.a029314"},{"key":"3","doi-asserted-by":"crossref","unstructured":"Camilleri, M., Madsen, K., Spiller, R., Greenwood-Van Meerveld, B. and Verne, G.N. (2012): Intestinal barrier function in health and gastrointestinal disease. Neurogastroenterol. Motil., <b>24<\/b>, 503-512.","DOI":"10.1111\/j.1365-2982.2012.01921.x"},{"key":"4","doi-asserted-by":"crossref","unstructured":"Cao, M., Yang, M., Ou, Z., Li, D., Geng, L., Chen, P., Chen, H. and Gong, S. (2014): Involvement of aquaporins in a mouse model of rotavirus diarrhea. Virol. Sin., <b>29<\/b>, 211-217.","DOI":"10.1007\/s12250-014-3469-z"},{"key":"5","doi-asserted-by":"crossref","unstructured":"Dong, L., Xie, J., Wang, Y., Jiang, H., Chen, K., Li, D., Wang, J., Liu, Y., He, J., Zhou, J., Zhang, L., Lu, X., Zou, X., Wang, X.Y., Wang, Q., Chen, Z. and Zuo, D. (2022): Mannose ameliorates experimental colitis by protecting intestinal barrier integrity. Nat. Commun., <b>13<\/b>, 4804.","DOI":"10.1038\/s41467-022-32505-8"},{"key":"6","doi-asserted-by":"crossref","unstructured":"Du, L., Zhu, L., Lu, X., Yu, Y., Liu, P. and Pan, J. (2023): Inhibition of the MLCK\/MLC2 pathway protects against intestinal heat stroke-induced injury in rats. J. Therm. Biol., <b>116<\/b>, 103655.","DOI":"10.1016\/j.jtherbio.2023.103655"},{"key":"7","doi-asserted-by":"crossref","unstructured":"Fan, P., Tan, Y., Jin, K., Lin, C., Xia, S., Han, B., Zhang, F., Wu, L. and Ma, X. (2017): Supplemental lipoic acid relieves post-weaning diarrhoea by decreasing intestinal permeability in rats. J. Anim. Physiol. Anim. Nutr. (Berl.), <b>101<\/b>, 136-146.","DOI":"10.1111\/jpn.12427"},{"key":"8","doi-asserted-by":"crossref","unstructured":"Groschwitz, K.R. and Hogan, S.P. (2009): Intestinal barrier function: molecular regulation and disease pathogenesis. J. Allergy Clin. Immunol., <b>124<\/b>, 3-20, quiz, 21-22.","DOI":"10.1016\/j.jaci.2009.05.038"},{"key":"9","doi-asserted-by":"crossref","unstructured":"Guan, Z., Zhao, Q., Huang, Q., Zhao, Z., Zhou, H., He, Y., Li, S. and Wan, S. (2021): Modified Renshen Wumei Decoction Alleviates Intestinal Barrier Destruction in Rats with Diarrhea. J. Microbiol. Biotechnol., <b>31<\/b>, 1295-1304.","DOI":"10.4014\/jmb.2106.06037"},{"key":"10","doi-asserted-by":"crossref","unstructured":"Hao, Z. and Wang, P. (2020): Lenvatinib in Management of Solid Tumors. Oncologist, <b>25<\/b>, e302-e310.","DOI":"10.1634\/theoncologist.2019-0407"},{"key":"11","doi-asserted-by":"crossref","unstructured":"Huang, H., Liao, D., Liang, L., Song, L. and Zhao, W. (2015): Genistein inhibits rotavirus replication and upregulates AQP4 expression in rotavirus-infected Caco-2 cells. Arch. Virol., <b>160<\/b>, 1421-1433.","DOI":"10.1007\/s00705-015-2404-4"},{"key":"12","doi-asserted-by":"crossref","unstructured":"Huang, L., Jiang, S. and Shi, Y. (2020a): Tyrosine kinase inhibitors for solid tumors in the past 20 years (2001-2020). J. Hematol. Oncol., <b>13<\/b>, 143.","DOI":"10.1186\/s13045-020-00977-0"},{"key":"13","doi-asserted-by":"crossref","unstructured":"Huang, S., Fu, Y., Xu, B., Liu, C., Wang, Q., Luo, S., Nong, F., Wang, X., Huang, S., Chen, J., Zhou, L. and Luo, X. (2020b): Wogonoside alleviates colitis by improving intestinal epithelial barrier function via the MLCK\/pMLC2 pathway. Phytomedicine, <b>68<\/b>, 153179.","DOI":"10.1016\/j.phymed.2020.153179"},{"key":"14","doi-asserted-by":"crossref","unstructured":"Inukai, Y., Yamamoto, K., Honda, T., Ito, T., Imai, N., Ishizu, Y., Nakamura, M., Kawashima, H. and Ishigami, M. (2023): Differences in the Intestinal Microbiome Associated with Diarrhea during Lenvatinib Treatment for Hepatocellular Carcinoma. Dig. Dis., <b>41<\/b>, 138-147.","DOI":"10.1159\/000524298"},{"key":"15","doi-asserted-by":"crossref","unstructured":"Keely, S.J. and Barrett, K.E. (2022): Intestinal secretory mechanisms and diarrhea. Am. J. Physiol. Gastrointest. Liver Physiol., <b>322<\/b>, G405-G420.","DOI":"10.1152\/ajpgi.00316.2021"},{"key":"16","doi-asserted-by":"crossref","unstructured":"Khoshbin, K. and Camilleri, M. (2020): Effects of dietary components on intestinal permeability in health and disease. Am. J. Physiol. Gastrointest. Liver Physiol., <b>319<\/b>, G589-G608.","DOI":"10.1152\/ajpgi.00245.2020"},{"key":"17","doi-asserted-by":"crossref","unstructured":"Kim, Y., Quach, A., Das, S. and Barrett, K.E. (2020): Potentiation of calcium-activated chloride secretion and barrier dysfunction may underlie EGF receptor tyrosine kinase inhibitor-induced diarrhea. Physiol. Rep., <b>8<\/b>, e14490.","DOI":"10.14814\/phy2.14490"},{"key":"18","doi-asserted-by":"crossref","unstructured":"Koyama, Y., Yamamoto, T., Tani, T., Nihei, K., Kondo, D., Funaki, H., Yaoita, E., Kawasaki, K., Sato, N., Hatakeyama, K. and Kihara, I. (1999): Expression and localization of aquaporins in rat gastrointestinal tract. Am. J. Physiol., <b>276<\/b>, C621-C627.","DOI":"10.1152\/ajpcell.1999.276.3.C621"},{"key":"19","doi-asserted-by":"publisher","unstructured":"Kudo, M., Finn, R.S., Qin, S., Han, K.H., Ikeda, K., Piscaglia, F., Baron, A., Park, J.W., Han, G., Jassem, J., Blanc, J.F., Vogel, A., Komov, D., Evans, T.R., Lopez, C., Dutcus, C., Guo, M., Saito, K., Kraljevic, S., Tamai, T., Ren, M. and Cheng, A.L. (2018): Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial. Lancet, <b>391<\/b>, 1163-1173.","DOI":"10.1016\/S0140-6736(18)30207-1"},{"key":"20","doi-asserted-by":"crossref","unstructured":"Kumar, V., Kaur, N., Sahu, S., Sharma, V., Kumar, D., Sharma, A. and Wadhwa, P. (2023): Role of Tyrosine Kinases and their Inhibitors in Cancer Therapy: A Comprehensive Review. Curr. Med. Chem., <b>30<\/b>, 1464-1481.","DOI":"10.2174\/0929867329666220727122952"},{"key":"21","doi-asserted-by":"crossref","unstructured":"Laforenza, U. (2012): Water channel proteins in the gastrointestinal tract. Mol. Aspects Med., <b>33<\/b>, 642-650.","DOI":"10.1016\/j.mam.2012.03.001"},{"key":"22","doi-asserted-by":"crossref","unstructured":"Liao, S., Gan, L., Lv, L. and Mei, Z. (2020): The regulatory roles of aquaporins in the digestive system. Genes Dis., <b>8<\/b>, 250-258.","DOI":"10.1016\/j.gendis.2019.12.011"},{"key":"23","doi-asserted-by":"crossref","unstructured":"Liu, J., Yan, S., Du, J., Teng, L., Yang, R., Xu, P. and Tao, W. (2024a): Mechanism and treatment of diarrhea associated with tyrosine kinase inhibitors. Heliyon, <b>10<\/b>, e27531.","DOI":"10.1016\/j.heliyon.2024.e27531"},{"key":"24","doi-asserted-by":"crossref","unstructured":"Liu, S., Zhao, S., Cheng, Z., Ren, Y., Shi, X., Mu, J., Ge, X., Dai, Y., Li, L. and Zhang, Z. (2024b): Akkermansia muciniphila Protects Against Antibiotic-Associated Diarrhea in Mice. Probiotics Antimicrob. Proteins, <b>16<\/b>, 1190-1204.","DOI":"10.1007\/s12602-023-10101-6"},{"key":"25","doi-asserted-by":"crossref","unstructured":"Lv, H., Li, Y., Xue, C., Dong, N., Bi, C. and Shan, A. (2022): Aquaporin: targets for dietary nutrients to regulate intestinal health. J. Anim. Physiol. Anim. Nutr. (Berl.), <b>106<\/b>, 167-180.","DOI":"10.1111\/jpn.13539"},{"key":"26","doi-asserted-by":"crossref","unstructured":"MA, T. &amp; VERKMAN, A. S. (1999) Aquaporin water channels in gastrointestinal physiology. J Physiol; 517 (Pt 2)(Pt 2): 317-326.","DOI":"10.1111\/j.1469-7793.1999.0317t.x"},{"key":"27","doi-asserted-by":"crossref","unstructured":"Mongre, R.K., Mishra, C.B., Shukla, A.K., Prakash, A., Jung, S., Ashraf-Uz-Zaman, M. and Lee, M.S. (2021): Emerging Importance of Tyrosine Kinase Inhibitors against Cancer: Quo Vadis to Cure? Int. J. Mol. Sci., <b>22<\/b>, 11659.","DOI":"10.3390\/ijms222111659"},{"key":"28","doi-asserted-by":"crossref","unstructured":"Motzer, R.J., Hutson, T.E., Glen, H., Michaelson, M.D., Molina, A., Eisen, T., Jassem, J., Zolnierek, J., Maroto, J.P., Mellado, B., Melichar, B., Tomasek, J., Kremer, A., Kim, H.J., Wood, K., Dutcus, C. and Larkin, J. (2015): Lenvatinib, everolimus, and the combination in patients with metastatic renal cell carcinoma: a randomised, phase 2, open-label, multicentre trial. Lancet Oncol., <b>16<\/b>, 1473-1482.","DOI":"10.1016\/S1470-2045(15)00290-9"},{"key":"29","doi-asserted-by":"crossref","unstructured":"Motzer, R.J., Taylor, M.H., Evans, T.R., Okusaka, T., Glen, H., Lubiniecki, G.M., Dutcus, C., Smith, A.D., Okpara, C.E., Hussein, Z., Hayato, S., Tamai, T. and Makker, V. (2022): Lenvatinib dose, efficacy, and safety in the treatment of multiple malignancies. Expert Rev. Anticancer Ther., <b>22<\/b>, 383-400.","DOI":"10.1080\/14737140.2022.2039123"},{"key":"30","doi-asserted-by":"crossref","unstructured":"Pottier, C., Fresnais, M., Gilon, M., J\u00e9rusalem, G., Longuesp\u00e9e, R. and Sounni, N.E. (2020): Tyrosine Kinase Inhibitors in Cancer: Breakthrough and Challenges of Targeted Therapy. Cancers (Basel), <b>12<\/b>, 731.","DOI":"10.3390\/cancers12030731"},{"key":"31","doi-asserted-by":"crossref","unstructured":"Qin, S., Li, A., Yi, M., Yu, S., Zhang, M. and Wu, K. (2019): Recent advances on anti-angiogenesis receptor tyrosine kinase inhibitors in cancer therapy. J. Hematol. Oncol., <b>12<\/b>, 27.","DOI":"10.1186\/s13045-019-0718-5"},{"key":"32","doi-asserted-by":"crossref","unstructured":"Rohr, M.W., Narasimhulu, C.A., Rudeski-Rohr, T.A. and Parthasarathy, S. (2020): Negative Effects of a High-Fat Diet on Intestinal Permeability: A Review. Adv. Nutr., <b>11<\/b>, 77-91.","DOI":"10.1093\/advances\/nmz061"},{"key":"33","doi-asserted-by":"crossref","unstructured":"Sakai, H., Sagara, A., Matsumoto, K., Jo, A., Hirosaki, A., Takase, K., Sugiyama, R., Sato, K., Ikegami, D., Horie, S., Matoba, M. and Narita, M. (2014): Neutrophil recruitment is critical for 5-fluorouracil-induced diarrhea and the decrease in aquaporins in the colon. Pharmacol. Res., <b>87<\/b>, 71-79.","DOI":"10.1016\/j.phrs.2014.05.012"},{"key":"34","doi-asserted-by":"crossref","unstructured":"Salvo Romero, E., Alonso Cotoner, C., Pardo Camacho, C., Casado Bedmar, M. and Vicario, M. (2015): The intestinal barrier function and its involvement in digestive disease. Rev. Esp. Enferm. Dig., <b>107<\/b>, 686-696.","DOI":"10.17235\/reed.2015.3846\/2015"},{"key":"35","doi-asserted-by":"crossref","unstructured":"Schoultz, I. and Keita, \u00c5. (1909): V. (2020): The Intestinal Barrier and Current Techniques for the Assessment of Gut Permeability. Cells, <b>9<\/b>, 1909.","DOI":"10.3390\/cells9081909"},{"key":"36","doi-asserted-by":"crossref","unstructured":"Shyam Sunder, S., Sharma, U.C. and Pokharel, S. (2023): Adverse effects of tyrosine kinase inhibitors in cancer therapy: pathophysiology, mechanisms and clinical management. Signal Transduct. Target. Ther., <b>8<\/b>, 262.","DOI":"10.1038\/s41392-023-01469-6"},{"key":"37","doi-asserted-by":"crossref","unstructured":"Stein, A., Voigt, W. and Jordan, K. (2010): Chemotherapy-induced diarrhea: pathophysiology, frequency and guideline-based management. Ther. Adv. Med. Oncol., <b>2<\/b>, 51-63.","DOI":"10.1177\/1758834009355164"},{"key":"38","doi-asserted-by":"crossref","unstructured":"Suyama, K. and Iwase, H. (2018): Lenvatinib: A Promising Molecular Targeted Agent for Multiple Cancers. Cancer Control, <b>25<\/b>, 1073274818789361.","DOI":"10.1177\/1073274818789361"},{"key":"39","doi-asserted-by":"crossref","unstructured":"Suzuki, T. (2020): Regulation of the intestinal barrier by nutrients: the role of tight junctions. Anim. Sci. J., <b>91<\/b>, e13357.","DOI":"10.1111\/asj.13357"},{"key":"40","doi-asserted-by":"crossref","unstructured":"Tsimberidou, A.M. (2015): Targeted therapy in cancer. Cancer Chemother. Pharmacol., <b>76<\/b>, 1113-1132.","DOI":"10.1007\/s00280-015-2861-1"},{"key":"41","doi-asserted-by":"crossref","unstructured":"Turner, J.R. (2009): Intestinal mucosal barrier function in health and disease. Nat. Rev. Immunol., <b>9<\/b>, 799-809.","DOI":"10.1038\/nri2653"},{"key":"42","doi-asserted-by":"crossref","unstructured":"Vergoulidou, M. (2015): More than a Decade of Tyrosine Kinase Inhibitors in the Treatment of Solid Tumors: What We Have Learned and What the Future Holds. Biomark. Insights, <b>10<\/b> (Suppl 3), 33-40.","DOI":"10.4137\/BMI.S22436"},{"key":"43","doi-asserted-by":"crossref","unstructured":"Wang, T., Meng, X., Qian, M., Jin, S., Bao, R., Zhu, L. and Zhang, Q. (2025): <i>Helicobacter hepaticus<\/i> CdtB Triggers Colonic Mucosal Barrier Disruption in Mice via Epithelial Tight Junction Impairment Mediated by MLCK\/pMLC2 Signaling Pathway. Vet. Sci., <b>12<\/b>, 174.","DOI":"10.3390\/vetsci12020174"},{"key":"44","doi-asserted-by":"crossref","unstructured":"Xie, Y., Zhan, X., Tu, J., Xu, K., Sun, X., Liu, C., Ke, C., Cao, G., Zhou, Z. and Liu, Y. (2021): Atractylodes oil alleviates diarrhea-predominant irritable bowel syndrome by regulating intestinal inflammation and intestinal barrier via SCF\/c-kit and MLCK\/MLC2 pathways. J. Ethnopharmacol., <b>272<\/b>, 113925.","DOI":"10.1016\/j.jep.2021.113925"},{"key":"45","doi-asserted-by":"crossref","unstructured":"Yamamoto, T., Kuramoto, H. and Kadowaki, M. (2007): Downregulation in aquaporin 4 and aquaporin 8 expression of the colon associated with the induction of allergic diarrhea in a mouse model of food allergy. Life Sci., <b>81<\/b>, 115-120.","DOI":"10.1016\/j.lfs.2007.04.036"},{"key":"46","doi-asserted-by":"publisher","unstructured":"Yang, T., Wang, L., Sun, R., Chen, H., Zhang, H., Yu, Y., Wang, Y., Wang, G., Yu, Y. and Xie, K. (2016): HYDROGEN-RICH MEDIUM AMELIORATES LIPOPOLYSACCHARIDE-INDUCED BARRIER DYSFUNCTION VIA RHOA-MDIA1 SIGNALING IN CACO-2 CELLS. Shock, <b>45<\/b>, 228-237.","DOI":"10.1097\/SHK.0000000000000503"},{"key":"47","doi-asserted-by":"crossref","unstructured":"Ye, Y., Ran, J., Yang, B. and Mei, Z. (2023): Aquaporins in Digestive System. Adv. Exp. Med. Biol., <b>1398<\/b>, 145-154.","DOI":"10.1007\/978-981-19-7415-1_10"},{"key":"48","doi-asserted-by":"crossref","unstructured":"Zhang, D., Cheng, H., Zhang, Y., Zhou, Y., Wu, J., Liu, J., Feng, W. and Peng, C. (2023): Ameliorative effect of Aconite aqueous extract on diarrhea is associated with modulation of the gut microbiota and bile acid metabolism. Front. Pharmacol., <b>14<\/b>, 1189971.","DOI":"10.3389\/fphar.2023.1189971"},{"key":"49","doi-asserted-by":"crossref","unstructured":"Zhang, D., Yang, L., Su, W., Zhao, Y., Ma, X., Zhou, H., Xu, B., Zhang, K. and Ma, H. (2018): Aquaporin-4 Is Downregulated in the Basolateral Membrane of Ileum Epithelial Cells during Enterotoxigenic <i>Escherichia coli<\/i>-Induced Diarrhea in Mice. Front. Microbiol., <b>8<\/b>, 2655.","DOI":"10.3389\/fmicb.2017.02655"},{"key":"50","doi-asserted-by":"publisher","unstructured":"Zhang, Y., Wang, X., Sha, S., Liang, S., Zhao, L., Liu, L., Chai, N., Wang, H. and Wu, K. (2012): Berberine increases the expression of NHE3 and AQP4 in sennosideA-induced diarrhoea model. Fitoterapia, <b>83<\/b>, 1014-1022.","DOI":"10.1016\/j.fitote.2012.05.015"},{"key":"51","doi-asserted-by":"crossref","unstructured":"Zhao, G.P., Wang, X.Y., Li, J.W., Wang, R., Ren, F.Z., Pang, G.F. and Li, Y.X. (2021): Imidacloprid increases intestinal permeability by disrupting tight junctions. Ecotoxicol. Environ. Saf., <b>222<\/b>, 112476.","DOI":"10.1016\/j.ecoenv.2021.112476"},{"key":"52","doi-asserted-by":"crossref","unstructured":"Zhao, X., Liang, B., Li, C. and Wang, W. (2023): Expression Regulation and Trafficking of Aquaporins. Adv. Exp. Med. Biol., <b>1398<\/b>, 39-51.","DOI":"10.1007\/978-981-19-7415-1_3"}],"container-title":["The Journal of Toxicological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jts\/50\/12\/50_677\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T04:07:29Z","timestamp":1764994049000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jts\/50\/12\/50_677\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":52,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.2131\/jts.50.677","relation":{},"ISSN":["0388-1350","1880-3989"],"issn-type":[{"value":"0388-1350","type":"print"},{"value":"1880-3989","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]}}}